Cargando…

A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021

Cannabidiol, a non-psychoactive component extracted from the plant cannabis sativa, has gained growing focus in recent years since its extensive pharmacology effects have been founded. The purpose of this study intends to reveal the hot spots and frontiers of cannabidiol research using bibliometrics...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liu, Liu, Jianxing, Zhao, Ming, Cai, Meiming, Lei, Fanzhang, Zeng, Xiaofeng, Zhu, Bofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673983/
https://www.ncbi.nlm.nih.gov/pubmed/36408229
http://dx.doi.org/10.3389/fphar.2022.969883
_version_ 1784833061151571968
author Liu, Liu
Liu, Jianxing
Zhao, Ming
Cai, Meiming
Lei, Fanzhang
Zeng, Xiaofeng
Zhu, Bofeng
author_facet Liu, Liu
Liu, Jianxing
Zhao, Ming
Cai, Meiming
Lei, Fanzhang
Zeng, Xiaofeng
Zhu, Bofeng
author_sort Liu, Liu
collection PubMed
description Cannabidiol, a non-psychoactive component extracted from the plant cannabis sativa, has gained growing focus in recent years since its extensive pharmacology effects have been founded. The purpose of this study intends to reveal the hot spots and frontiers of cannabidiol research using bibliometrics and data visualization methods. A total of 3,555 publications with 106,793 citations from 2004 to 2021 related to cannabidiol were retrieved in the Web of Science database, and the co-authorships, research categories, keyword burst, and reference citations in the cannabidiol field were analyzed and visualized by VOSviewer and Citespace software. Great importance has been attached to the pharmacology or pharmacy values of cannabidiol, especially in the treatment of neuropsychiatric disorders, such as epilepsy, anxiety, and schizophrenia. The mechanisms or targets of the cannabidiol have attracted the extreme interest of the researchers, a variety of receptors including cannabinoids type 1, cannabinoids type 2, 5-hydroxytriptamine1A, and G protein-coupled receptor 55 were involved in the pharmacology effects of cannabidiol. Moreover, the latest developed topic has focused on the positive effects of cannabidiol on substance use disorders. In conclusion, this study reveals the development and transformation of knowledge structures and research hotspots in the cannabidiol field from a bibliometrics perspective, exploring the possible directions of future research.
format Online
Article
Text
id pubmed-9673983
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96739832022-11-19 A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021 Liu, Liu Liu, Jianxing Zhao, Ming Cai, Meiming Lei, Fanzhang Zeng, Xiaofeng Zhu, Bofeng Front Pharmacol Pharmacology Cannabidiol, a non-psychoactive component extracted from the plant cannabis sativa, has gained growing focus in recent years since its extensive pharmacology effects have been founded. The purpose of this study intends to reveal the hot spots and frontiers of cannabidiol research using bibliometrics and data visualization methods. A total of 3,555 publications with 106,793 citations from 2004 to 2021 related to cannabidiol were retrieved in the Web of Science database, and the co-authorships, research categories, keyword burst, and reference citations in the cannabidiol field were analyzed and visualized by VOSviewer and Citespace software. Great importance has been attached to the pharmacology or pharmacy values of cannabidiol, especially in the treatment of neuropsychiatric disorders, such as epilepsy, anxiety, and schizophrenia. The mechanisms or targets of the cannabidiol have attracted the extreme interest of the researchers, a variety of receptors including cannabinoids type 1, cannabinoids type 2, 5-hydroxytriptamine1A, and G protein-coupled receptor 55 were involved in the pharmacology effects of cannabidiol. Moreover, the latest developed topic has focused on the positive effects of cannabidiol on substance use disorders. In conclusion, this study reveals the development and transformation of knowledge structures and research hotspots in the cannabidiol field from a bibliometrics perspective, exploring the possible directions of future research. Frontiers Media S.A. 2022-11-04 /pmc/articles/PMC9673983/ /pubmed/36408229 http://dx.doi.org/10.3389/fphar.2022.969883 Text en Copyright © 2022 Liu, Liu, Zhao, Cai, Lei, Zeng and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Liu
Liu, Jianxing
Zhao, Ming
Cai, Meiming
Lei, Fanzhang
Zeng, Xiaofeng
Zhu, Bofeng
A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
title A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
title_full A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
title_fullStr A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
title_full_unstemmed A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
title_short A bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
title_sort bibliometrics and visualization analysis of cannabidiol research from 2004 to 2021
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673983/
https://www.ncbi.nlm.nih.gov/pubmed/36408229
http://dx.doi.org/10.3389/fphar.2022.969883
work_keys_str_mv AT liuliu abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT liujianxing abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT zhaoming abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT caimeiming abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT leifanzhang abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT zengxiaofeng abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT zhubofeng abibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT liuliu bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT liujianxing bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT zhaoming bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT caimeiming bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT leifanzhang bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT zengxiaofeng bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021
AT zhubofeng bibliometricsandvisualizationanalysisofcannabidiolresearchfrom2004to2021